Q3
BCTX — Q3 FY2026 Financial Report Analysis
BriaCell's net loss widened 17% to $7.2M in the quarter to April 30, 2026 as Phase 3 Bria-IMT costs rose; loss per share fell only because the share count grew ~19x, and the going-concern warning remains.